FrancophonIA/ELRC3.0 huggingface dataset:
English: • are allergic to migalastat or any of the other ingredients of this medicine (listed in section 6) Warnings and precautions
Norwegian Bokmål: Bruk ikke Galafold: - dersom du er allergisk overfor migalastat eller noen av de andre innholdsstoffene i dette legemidlet (listet opp i avsnitt 6).
English: • Sensation of spinning
Norwegian Bokmål: • Følelse av å snurre rundt
English: g.6736_11545del c.370-533_c.1290+277del
Norwegian Bokmål: UKJENT (del Exon3 go g.6736_11545del c.370-533_c.1290+277del
English: c.140G>A or 141G>A
Norwegian Bokmål: c.140G>A eller 141G>A
English: Galafold is not recommended for use in patients with severe renal insufficiency, defined as estimated GFR less than 30 mL/min/1.73m
Norwegian Bokmål: Galafold anbefales ikke for bruk hos pasienter med alvorlig nedsatt nyrefunksjon, definert som estimert GFR på mindre enn 30 ml/min/1,73 m
English: In the ERT- naïve trial and open-label extension, renal function remained stable for up to 5 years of treatment with Galafold.
Norwegian Bokmål: I studien med ERT-naive og den åpne forlengelsesstudien forble nyrefunksjonen stabil i 3 år med behandling med Galafold.
English: c.T1147C or c.C1149G or c.C1149A
Norwegian Bokmål: c.T1147C eller c.C1149G eller c.C1149A
English: c.611G>A or 612G>A
Norwegian Bokmål: c.611G>A eller 612G>A
English: c.A504C or c.A504T
Norwegian Bokmål: c.A504C eller c.A504T
English: How to store Galafold
Norwegian Bokmål: Hvordan du oppbevarer Galafold
English: (dyspnoea)
Norwegian Bokmål: (dyspepsi)
English: c.712A>C or c.714T>A or c.714T>G
Norwegian Bokmål: c.712A>C eller c.714T>A eller c.714T>G
English: g.10237_11932del/11933_12083i nv/12084_12097del
Norwegian Bokmål: g.10237_11932del/11933_12083i nv/12084_12097del g.>5.5kbdel til 3UTR
English: c.442A>C or c.444T>A or c.444T>G
Norwegian Bokmål: c.442A>C eller c.444T>A eller c.444T>G
English: c.A924T or c.A924C
Norwegian Bokmål: c.A924T eller c.A924C
English: Galafold is not recommended for use in patients with Fabry disease who have estimated GFR less than 30 mL/min/1.73 m
Norwegian Bokmål: Galafold er ikke anbefalt for bruk hos pasienter med Fabrys sykdom som har en estimert GFR på mindre enn 30 ml/min/1,73 m
English: Galafold is not intended for concomitant use with enzyme replacement therapy (see section 4.4).
Norwegian Bokmål: Galafold er ikke beregnet for samtidig bruk med enzymerstatningsterapi (se pkt.
English: (proteinuria)
Norwegian Bokmål: (proteinuri)
English: c.G140A or G141A
Norwegian Bokmål: c.G140A eller G141A
English: c.504A>C or c.504A>T
Norwegian Bokmål: c.504A>C eller c.504A>T
English: c.369+3_639+954del3129insT UNKNOWN (del Exon3 and 4?)
Norwegian Bokmål: c.369+3_639+954del3129insT UKJENT (del Exon3 go g.6009_9741del
English: The mean change from baseline in LVMi at Month 18 to 24 in patients with left ventricular hypertrophy at baseline (females with baseline LVMi > 95 g/m or males with baseline LVMi > 115 g/m 2) was -18.6 (95% CI: -38.2, 1.0; n=8).
Norwegian Bokmål: Gjennomsnittlig endring i LVMi fra baseline etter 18 til 24 måneder hos pasienter med venstre ventrikkel hypertrofi ved baseline (kvinner med baseline-LVMi på > 95 g/m eller menn med baseline-LVMi på > 115 g/m2) var -18,6 (95 % KI: -38,2, 1,0; n=8).
English: Hepatic impairment No dosage adjustment of Galafold is required in patients with hepatic impairment (see section 5.2).
Norwegian Bokmål: Nedsatt leverfunksjon Dosejustering av Galafold er ikke nødvendig for pasienter med nedsatt leverfunksjon (se pkt.
English: c.924A>T or c.924A>C
Norwegian Bokmål: c.924A>T eller c.924A>C
English: Table 2: Galafold (migalastat) amenability table
Norwegian Bokmål: Tabell 2: Tabell over mottakelighet overfeller Galafold (migalastat)
English: c.G412A or c.G412C
Norwegian Bokmål: c.G412A eller c.G412C
English: c.148T>C or c.150C>G or c.150C>A
Norwegian Bokmål: c.148T>C eller c.150C>G eller c.150C>A
English: c.1147T>C or c.1149C>G or c.1149C>A
Norwegian Bokmål: c.1147T>C eller c.1149C>G eller c.1149C>A
English: Abdominal pain Constipation Dry mouth
Norwegian Bokmål: Abdominalsmerte Konstipasjon Munntørrhet Plutselig avføringstrang Dyspepsi
English: c.1095T>A or c.1095T>G c.T1095A or c.T1095G
Norwegian Bokmål: c.1095T>A eller c.1095T>G c.T1095A eller c.T1095G
English: (hypoaesthesia)
Norwegian Bokmål: (hypoestesi)
English: c.A124C or c.A124T
Norwegian Bokmål: c.A124C eller c.A124T
English: c.70T>C or c.70T>A
Norwegian Bokmål: c.70T>C eller c.70T>A
English: c.280T>A or c.281G>C
Norwegian Bokmål: c.280T>A eller c.281G>C
English: c.T187A or c.G188C
Norwegian Bokmål: c.T187A eller c.G188C
English: c.216G>A or c.216G>T or c.216G>C
Norwegian Bokmål: c.216G>A eller c.216G>T eller c.216G>C
English: • Sudden need to defecate
Norwegian Bokmål: • Plutselig trang til avføring
English: c.G982A or c.G982C
Norwegian Bokmål: c.G982A eller c.G982C
English: How to take Galafold
Norwegian Bokmål: Hvordan du bruker Galafold
English: c.817T>C or c.819T>A or c.819T>G
Norwegian Bokmål: c.817T>C eller c.819T>A eller c.819T>G
English: c.412G>A or c.412G>C
Norwegian Bokmål: c.412G>A eller c.412G>C
English: c.G285T or c.G285C
Norwegian Bokmål: c.G285T eller c.G285C
English: c.71G>A or c.72G>A
Norwegian Bokmål: c.71G>A eller c.72G>A
English: Dyspnoea Epistaxis
Norwegian Bokmål: Dyspné Epistaksis
English: After follow up in the OLE, the mean change from baseline in LVMi at Month 36 was -8.3 (95% CI: -17.1, 0.4; n=25) and at Month 48 was -9.1 (95% CI: -20.3, 2.0; n=18).
Norwegian Bokmål: Etter oppfølging i den åpne forlengelsesstudien var gjennomsnittlig endring i LVMi fra baseline etter 36 måneder -8,3 (95 % KI: -17,1, 0,4; n=25) og ved måned 48 -9,1 (95 % KI: -20,3, 2,0; n= 18).
English: c.T148C or c.C150G or c.C150A F50L
Norwegian Bokmål: c.T148C eller c.C150G eller c.C150A
English: c.T70C or c.T70A
Norwegian Bokmål: c.T70C eller c.T70A
English: c.982G>A or c.982G>C
Norwegian Bokmål: c.982G>A eller c.982G>C
English: c.228G>C or c.228G>A or c.228G>T
Norwegian Bokmål: c.228G>C eller c.228G>A eller c.228G>T
English: c.G540C or c.G540T
Norwegian Bokmål: c.G540C eller c.G540T
English: c.G471C or c.G471T
Norwegian Bokmål: c.G471C eller c.G471T
English: c.T166A or c.G167C
Norwegian Bokmål: c.T166A eller c.G167C
English: If more than 12 hours has passed you should resume taking Galafold at the next planned dosing day and time according to your every other day dosing schedule.. Do not take two capsules to make up for your missed dose.
Norwegian Bokmål: Hvis det har gått mer enn 12 timer, skal du fortsette å ta Galafold på neste planlagte doseringsdag og -tid i henhold til doseringsplanen med annenhver dag.
English: If you are pregnant, think you may be pregnant, or are planning to have a baby, do not take this medicine until you have checked with your doctor, pharmacist, or nurse.
Norwegian Bokmål: Rådfør deg med lege, apotek eller sykepleier før du tar dette legemidlet dersom du er gravid, tror du kan være gravid eller planlegger å bli gravid.
English: c.G261C or c.G261T
Norwegian Bokmål: c.G261C eller c.G261T
English: c.G71A or c.G72A
Norwegian Bokmål: c.G71A eller c.G72A
English: c.153G>A or c.153G>T or c.153G>C
Norwegian Bokmål: c.153G>A eller c.153G>T eller c.153G>C
English: g.2594_10904dup c.195-2500_999+197dup
Norwegian Bokmål: Proteinsekvensendring g.2594_10904dup c.195-2500_999+197dup g.2934_6378del
English: c.187T>A or c.188G>C
Norwegian Bokmål: c.187T>A eller c.188G>C
English: The mean annualised rate of change from baseline in eGFRCKD-EPI in patients treated for 30 months with Galafold was -1.72 mL/min/1.73 m
Norwegian Bokmål: Gjennomsnittlig årlig endringsrate fra baseline for eGFRCKD-EPI i pasienter behandlet i 30 måneder med Galafold var -1,72 ml/min/1,73 m (95 % KI: -2,653, -0,782; n=31).
English: c.261G>C or c.261G>T
Norwegian Bokmål: c.261G>C eller c.261G>T
English: c.612G>T or c.612G>C
Norwegian Bokmål: c.612G>T eller c.612G>C
English: c.124A>C or c.124A>T
Norwegian Bokmål: c.124A>C eller c.124A>T
English: c.G612T or c.G612C
Norwegian Bokmål: c.G612T eller c.G612C
English: c.285G>T or c.285G>C
Norwegian Bokmål: c.285G>T eller c.285G>C
English: c.471G>C or c.471G>T
Norwegian Bokmål: c.471G>C eller c.471G>T
English: c.G132T or c.G132C
Norwegian Bokmål: c.G132T eller c.G132C
English: UNKNOWN (del Exon3?)
Norwegian Bokmål: UKJENT (del Exon3?)
English: c.T514A or c.G515C
Norwegian Bokmål: c.T514A eller c.G515C
English: What Galafold contains - The active substance is migalastat.
Norwegian Bokmål: Sammensetning av Galafold - Virkestoffet er migalastat.
English: • Indigestion (dyspepsia)
Norwegian Bokmål: • Neseblødning (epistaksis)
English: c.G243T or c.G243C
Norwegian Bokmål: c.G243T eller c.G243C
English: c.T280A or c.G281C
Norwegian Bokmål: c.T280A eller c.G281C
English: c.G609C or c.G609T
Norwegian Bokmål: c.G609C eller c.G609T
English: A decision must be made whether to discontinue breast-feeding or to discontinue Galafold, taking into account the benefit of breast-feeding for the child relative to the benefit of therapy for the mother.
Norwegian Bokmål: Tatt i betraktning fordelene av amming for barnet og fordelene av behandling for moren, må det tas en beslutning om ammingen skal opphøre eller behandlingen med Galafold skal avsluttes.
English: c.166T>A or c.167G>C
Norwegian Bokmål: c.166T>A eller c.167G>C
English: Paraesthesia Dizziness Hypoaesthesia
Norwegian Bokmål: Parestesi Svimmelhet Hypoestesi
English: c.G144T or c.G144C
Norwegian Bokmål: c.G144T eller c.G144C
English: c.T784A or c.T784C
Norwegian Bokmål: c.T784A eller c.T784C
English: c.514T>A or c.515G>C
Norwegian Bokmål: c.514T>A eller c.515G>C
English: c.243G>T or c.243G>C
Norwegian Bokmål: c.243G>T eller c.243G>C
English: c.T154A or c.G155C
Norwegian Bokmål: c.T154A eller c.G155C
English: c.A840T or c.A840C
Norwegian Bokmål: c.A840T eller c.A840C
English: c.132G>T or c.132G>C
Norwegian Bokmål: c.132G>T eller c.132G>C
English: c.G567C or c.G567T
Norwegian Bokmål: c.G567C eller c.G567T
English: c.609G>C or c.609G>T
Norwegian Bokmål: c.609G>C eller c.609G>T
English: c.144G>T or c.144G>C
Norwegian Bokmål: c.144G>T eller c.144G>C
English: c.540G>C or c.540G>T
Norwegian Bokmål: c.540G>C eller c.540G>T
English: UNKNOWN (del Exon1_2?)
Norwegian Bokmål: UKJENT (del Exon1_2?)
English: c.A588T or c.A588C
Norwegian Bokmål: c.A588T eller c.A588C
English: c.G831T or c.G831C
Norwegian Bokmål: c.G831T eller c.G831C
English: On your first day of taking this medicine from a new blister sleeve, record the date on the blister sleeve.
Norwegian Bokmål: Skriv datoen på blisterpakningen den første dagen du tar dette legemidlet fra en ny blisterpakning.
English: c.G141C or c.G141T
Norwegian Bokmål: c.G141C eller c.G141T
English: c.567G>C or c.567G>T
Norwegian Bokmål: c.567G>C eller c.567G>T
English: c.108G>C or c.108G>T
Norwegian Bokmål: c.108G>C eller c.108G>T
English: UNKNOWN (del Exon5_7?)
Norwegian Bokmål: UKJENT (del Exon5_7?)
English: c.141G>C or c.141G>T
Norwegian Bokmål: c.141G>C eller c.141G>T
English: c.831G>T or c.831G>C
Norwegian Bokmål: c.831G>T eller c.831G>C
English: c.784T>A or c.784T>C
Norwegian Bokmål: c.784T>A eller c.784T>C
English: p.G258fx*5
Norwegian Bokmål: Proteinsekvensendring p.G258fx*5
English: Protein Sequence change c.1202C>G or c.1202C>A c.C1202G or c.C1202A
Norwegian Bokmål: W399S c.1202C>G eller c.1202C>A c.C1202G eller c.C1202A S401X c.1215T>A
English: c.T667A or c.G668C
Norwegian Bokmål: c.T667A eller c.G668C
English: c.G439A or c.G439C
Norwegian Bokmål: c.G439A eller c.G439C
English: c.T337C or c.T339A or c.T339G F113L
Norwegian Bokmål: c.T337C eller c.T339A eller c.T339G
English: c.G216A or c.G216T or c.G216C M72I
Norwegian Bokmål: c.G216A eller c.G216T eller c.G216C
English: c.G108C or c.G108T
Norwegian Bokmål: c.G108C eller c.G108T
English: c.T817C or c.T819A or c.T819G F273L
Norwegian Bokmål: c.T817C eller c.T819A eller c.T819G
English: Transient and fully reversible infertility in male rats was associated with migalastat treatment at all doses assessed.
Norwegian Bokmål: Alle doser av migalasat som ble undersøkt var assosiert med forbigående og fullt reversibel infertilitet hos hannrotter.
English: c.G394A or c.G394C
Norwegian Bokmål: c.G394A eller c.G394C
English: c.439G>A or c.439G>C
Norwegian Bokmål: c.439G>A eller c.439G>C
English: c.870G>A or c.870G>C or c.870G>T
Norwegian Bokmål: c.870G>A eller c.870G>C eller c.870G>T
English: c.G861C or c.G861T
Norwegian Bokmål: c.G861C eller c.G861T
English: (paraesthesia)
Norwegian Bokmål: (parestesi)
English: c.888G>A or c.888G>T or c.888G>C
Norwegian Bokmål: c.888G>A eller c.888G>T eller c.888G>C
English: c.394G>A or c.394G>C
Norwegian Bokmål: c.394G>A eller c.394G>C
English: The change from baseline to Month 18 in LVMi (g/m 2) in patients with left ventricular hypertrophy (females with baseline LVMi > 95 g/m and males with baseline LVMi > 115 g/m2) was -8.4 (95% CI: -15.7, 2.6; n=13) for migalastat and 4.5 (95% CI: -10.7, 18.4; n=5) for ERT. After 30 months treatment with Galafold, the mean change from baseline in LVMi was -3.8 (95% CI: -8.9, 1.3; n=28) and the mean change from baseline in LVMi in patients with left ventricular hypertrophy at baseline was -10.0 (95% CI: -16.6, -3.3; n=10).
Norwegian Bokmål: Baseline-verdiene var 95,3 g/m for Galafold-armen og 92,9 g/m for ERT-armen og gjennomsnittlig endring fra baseline i LVMi ved måned 18 var -6,6 (95 % KI: -11,0, -2,1; n=31) for Galafold og -2,0 (95 % KI: -11,0, 7,0; n=13) for ERT. Endringen i LVMi (g/m 2) fra baseline til måned 18 hos pasienter med venstre ventrikkel hypertrofi (kvinner med baseline LVMi > 95 g/m og menn med baseline LVMi > 115 g/m2) var -8,4 (95 % KI: -15,7, 2,6; n=13) for migalastat og 4,5 (95 % KI: -10,7, 18,4; n=5) for ERT.
English: Check with your doctor, pharmacist, or nurse if you are not sure.
Norwegian Bokmål: Rådfør deg med lege, apotek eller sykepleier dersom du planlegger å bli gravid.
English: c.G486C or c.G486T
Norwegian Bokmål: c.G486C eller c.G486T
English: c.1196G>A or c.1197G>A c.G1196A or c.G1197A
Norwegian Bokmål: E398A c.1196G>A eller c.1197G>A c.G1196A eller c.G1197A W399X c.1196G>C
English: c.G837C or c.G837T
Norwegian Bokmål: c.G837C eller c.G837T
English: In a single dose study with Galafold in non-Fabry subjects with varying degrees of renal insufficiency, exposures were increased by 4.3-fold in subjects with severe renal impairment (GFR < 30 mL/min/1.73 m
Norwegian Bokmål: Galafold er ikke undersøkt hos pasienter med Fabrys sykdom som har en GFR under 30 ml/min/1,73 m2. I en enkeltdosestudie med Galafold hos personer uten Fabrys sykdom, men med varierende grad av nedsatt nyrefunksjon, ble eksponeringen 4,3 ganger større hos personer med alvorlig nedsatt nyrefunksjon (GFR < 30 ml/min/1,73 m
English: Disease Substrate
Norwegian Bokmål: Sykdomssubstrat
English: c.708G>C or c.708G>T
Norwegian Bokmål: c.708G>C eller c.708G>T
English: c.840A>T or c.840A>C
Norwegian Bokmål: c.840A>T eller c.840A>C
English: c.G936T or c.G936C
Norwegian Bokmål: c.G936T eller c.G936C
English: c.588A>T or c.588A>C
Norwegian Bokmål: c.588A>T eller c.588A>C
English: c.A868C or c.A868T
Norwegian Bokmål: c.A868C eller c.A868T
English: c.G963C or c.G963T
Norwegian Bokmål: c.G963C eller c.G963T
English: c.861G>C or c.861G>T
Norwegian Bokmål: c.861G>C eller c.861G>T
English: c.G126A or c.G126C or c.G126T M42I
Norwegian Bokmål: c.G126A eller c.G126C eller c.G126T
English: c.936G>T or c.936G>C
Norwegian Bokmål: c.936G>T eller c.936G>C
English: c.837G>C or c.837G>T
Norwegian Bokmål: c.837G>C eller c.837G>T
English: c.1045T>C or c.1045T>A c.T1045C or c.T1045A
Norwegian Bokmål: Proteinsekvensendring c.1045T>C eller c.1045T>A c.T1045C eller c.T1045A
English: Galafold 123 mg hard capsules Migalastat
Norwegian Bokmål: Galafold 123 mg harde kapsler migalastat
English: c.72G>C or c.72G>T
Norwegian Bokmål: c.72G>C eller c.72G>T
English: c.A712C or c.T714A or c.T714G S238R
Norwegian Bokmål: c.A712C eller c.T714A eller c.T714G
English: UNKNOWN (del Exon3_7?)
Norwegian Bokmål: UKJENT (del Exon3_7?)
English: c.667T>A or c.668G>C
Norwegian Bokmål: c.667T>A eller c.668G>C
English: c.1019G>A or c.1020G>A c.G1019A or c.G1020A
Norwegian Bokmål: W340R c.1019G>A eller c.1020G>A c.G1019A eller c.G1020A W340X c.1019G>C
English: c.978G>C or c.978G>T
Norwegian Bokmål: c.978G>C eller c.978G>T
English: c.288G>A or c.288G>T or c.288G>C
Norwegian Bokmål: c.288G>A eller c.288G>T eller c.288G>C
English: c.963G>C or c.963G>T
Norwegian Bokmål: c.963G>C eller c.963G>T
English: c.G561T or c.G561A or c.G561C M187I
Norwegian Bokmål: c.G561T eller c.G561A eller c.G561C
English: c.486G>C or c.486G>T
Norwegian Bokmål: c.486G>C eller c.486G>T
English: c.G228C or c.G228A or c.G228T M76I
Norwegian Bokmål: c.G228C eller c.G228A eller c.G228T
English: UNKNOWN (del Exon2_3?)
Norwegian Bokmål: UKJENT (del Exon2_3?)
English: c.720G>C or c.720G>T
Norwegian Bokmål: c.720G>C eller c.720G>T
English: c.678G>T or c.678G>C
Norwegian Bokmål: c.678G>T eller c.678G>C
English: c.G978C or c.G978T
Norwegian Bokmål: c.G978C eller c.G978T
English: c.C525G or c.C525A
Norwegian Bokmål: c.525C>G eller c.525C>A c.C525G eller c.C525A
English: c.729G>C or c.729G>T
Norwegian Bokmål: c.729G>C eller c.729G>T
English: c.G720C or c.G720T
Norwegian Bokmål: c.G720C eller c.G720T
English: c.G72C or c.G72T
Norwegian Bokmål: c.G72C eller c.G72T
English: c.G729C or c.G729T
Norwegian Bokmål: c.G729C eller c.G729T
English: c.G708C or c.G708T
Norwegian Bokmål: c.G708C eller c.G708T
English: c.337T>C or c.339T>A or c.339T>G
Norwegian Bokmål: Proteinsekvensendring c.337T>C eller c.339T>A eller c.339T>G
English: c.868A>C or c.868A>T
Norwegian Bokmål: c.868A>C eller c.868A>T
English: c.C279G or c.C279A
Norwegian Bokmål: c.279C>G eller c.279C>A c.C279G eller c.C279A
English: c.G678T or c.G678C
Norwegian Bokmål: c.G678T eller c.G678C
English: c.A886T or c.A886C
Norwegian Bokmål: c.A886T eller c.A886C
English: c.A442C or c.T444A or c.T444G S148R
Norwegian Bokmål: c.A442C eller c.T444A eller c.T444G
English: • Persistent itch (pruritus)
Norwegian Bokmål: • Kortpustethet (dyspné)
English: BLISTER FOIL
Norwegian Bokmål: BLISTERFOLIE
English: c.G870A or c.G870C or c.G870T M290I
Norwegian Bokmål: c.G870A eller c.G870C eller c.G870T
English: c.G153A or c.G153T or c.G153C M51I
Norwegian Bokmål: c.G153A eller c.G153T eller c.G153C
English: c.G786C or c.G786T
Norwegian Bokmål: c.G786C eller c.G786T
English: c.886A>T or c.886A>C
Norwegian Bokmål: c.886A>T eller c.886A>C
English: c.G888A or c.G888T or c.G888C M296I
Norwegian Bokmål: c.G888A eller c.G888T eller c.G888C
English: c.786G>C or c.786G>T
Norwegian Bokmål: c.786G>C eller c.786G>T
English: c.207C>A or c.207C>G
Norwegian Bokmål: c.207C>A eller c.207C>G c.C207A eller c.C207G
English: c.552T>A or c.552T>G
Norwegian Bokmål: c.552T>A eller c.552T>G c.T552A eller c.T552G
English: c.561G>T or c.561G>A or c.561G>C
Norwegian Bokmål: Proteinsekvensendring c.561G>T eller c.561G>A eller c.561G>C
English: c.G288A or c.G288T or c.G288C M96I
Norwegian Bokmål: c.G288A eller c.G288T eller c.G288C
English: c.T139C or c.T139A
Norwegian Bokmål: c.139T>C eller c.139T>A c.T139C eller c.T139A
English: MINIMUM PARTICULARS TO APPEAR ON INTERMEDIATE PACKAGING
Norwegian Bokmål: MINSTEKRAV TIL OPPLYSNINGER SOM SKAL ANGIS PÅ GJENNOMTRYKKSPAKNINGER (BLISTER)
English: c.1023A >C or c.1023A>T
Norwegian Bokmål: c.1023A >C eller c.1023A>T c.A1023C eller c.A1023T
English: Protein sequence change c.126G>A or c.126G>C or c.126G>T
Norwegian Bokmål: c.126G>A eller c.126G>C eller c.126G>T
English: Protein Sequence change p.T412Sfs*37
Norwegian Bokmål: p.T412Sfs*37
English: c.1034C>G or c.1034C>A c.C1034G or c.C1034A
Norwegian Bokmål: L344P c.1034C>G eller c.1034C>A c.C1034G eller c.C1034A S345X c.1042G>C
English: If you take more Galafold than you should
Norwegian Bokmål: Dersom du tar for mye av Galafold
English: c.C305G or c.C305A
Norwegian Bokmål: c.305C>G eller c.305C>A c.C305G eller c.C305A
English: c.519C>A or c.519C>G
Norwegian Bokmål: c.519C>A eller c.519C>G c.C519A eller c.C519G
English: c.C747G or c.C747A
Norwegian Bokmål: c.747C>G eller c.747C>A c.C747G eller c.C747A
English: c.T258G or c.T258A
Norwegian Bokmål: c.258T>G eller c.258T>A c.T258G eller c.T258A
English: In the ERT-naïve trial, Galafold resulted in a statistically significant decrease in LVMi (p< 0.05); the mean change from baseline in LVMi at Month 18 to 24 was -7.7 (95% CI: -15.4, -0.01; n=27).
Norwegian Bokmål: Gjennomsnittlig endring i LVMi fra baseline etter 18 til 24 måneder var -7,7 (95 % KI: -15,4, -0,01; n=27).
English: Protein Sequence change c.1030_1031insT
Norwegian Bokmål: Proteinsekvensendring c.1043_1044insG
English: galafold 123 mg hard capsules
Norwegian Bokmål: Galafold 123 mg harde kapsler
English: BLISTER SLEEVE
Norwegian Bokmål: Muskelspasmer Myalgi
English: c.G284A or c.G285A
Norwegian Bokmål: c.284G>A eller c.285G>A c.G284A eller c.G285A
English: c.1046G>A or c.1047G>A c.G1046A or c.G1047A
Norwegian Bokmål: W349R c.1046G>A eller c.1047G>A c.G1046A eller c.G1047A W349X c.1048G>C
English: c.816C>A or c.816C>G
Norwegian Bokmål: c.816C>A eller c.816C>G c.C816A eller c.C816G
English: c.1081G>A or c.1081G>C
Norwegian Bokmål: c.1081G>A eller c.1081G>C c.G1081A eller c.G1081C
English: c.C897G or c.C897A
Norwegian Bokmål: c.897C>G eller c.897C>A c.C897G eller c.C897A
English: • Pain
Norwegian Bokmål: • Smerter
English: c.T241C or c.T241A
Norwegian Bokmål: c.241T>C eller c.241T>A c.T241C eller c.T241A
English: c.830G>A or c.831G>A
Norwegian Bokmål: c.830G>A eller c.831G>A c.G830A eller c.G831A
English: c.785G>A or c.786G>A
Norwegian Bokmål: c.785G>A eller c.786G>A c.G785A eller c.G786A
English: c.T706C or c.T706A
Norwegian Bokmål: c.706T>C eller c.706T>A c.T706C eller c.T706A
English: c.G485A or c.G486A
Norwegian Bokmål: c.485G>A eller c.486G>A c.G485A eller c.G486A
English: c.T859C or c.T859A
Norwegian Bokmål: c.859T>C eller c.859T>A c.T859C eller c.T859A
English: c.T610C or c.T610A
Norwegian Bokmål: c.610T>C eller c.610T>A c.T610C eller c.T610A
English: c.C453G or c.C453A
Norwegian Bokmål: c.453C>G eller c.453C>A c.C453G eller c.C453A
English: c.1065C>A or c.1065C>G c.C1065A or c.C1065G
Norwegian Bokmål: c.456C>A eller c.456C>G c.C456A eller c.C456G
English: c.T894G or c.T894A
Norwegian Bokmål: c.894T>G eller c.894T>A c.T894G eller c.T894A
English: c.T102G or c.T102A
Norwegian Bokmål: c.102T>G eller c.102T>A c.T102G eller c.T102A
English: c.T676C or c.T676A
Norwegian Bokmål: c.676T>C eller c.676T>A c.T676C eller c.T676A
English: g.6547_9783del
Norwegian Bokmål: UKJENT (del Exon3 go g.6547_9783del
English: c.T402G or c.T402A
Norwegian Bokmål: c.402T>G eller c.402T>A c.T402G eller c.T402A
English: c.T960G or c.T960A
Norwegian Bokmål: c.960T>G eller c.960T>A c.T960G eller c.T960A
English: c.C233G or c.C233A
Norwegian Bokmål: c.233C>G eller c.233C>A c.C233G eller c.C233A
English: c.465T>A or c.465T>G
Norwegian Bokmål: c.465T>A eller c.465T>G c.T465A eller c.T465G
English: c.G131A or c.G132A
Norwegian Bokmål: c.131G>A eller c.132G>A c.G131A eller c.G132A
English: c.T484C or c.T484A
Norwegian Bokmål: c.484T>C eller c.484T>A c.T484C eller c.T484A
English: c.1074G>T or c.1074G>C
Norwegian Bokmål: c.1074G>T eller c.1074G>C c.G1074T eller c.G1074C
English: c.860G>A or c.861G>A
Norwegian Bokmål: c.860G>A eller c.861G>A c.G860A eller c.G861A
English: c.966C>A or c.966C>G
Norwegian Bokmål: c.966C>A eller c.966C>G c.C966A eller c.C966G
English: c.408T>A or c.408T>G
Norwegian Bokmål: c.408T>A eller c.408T>G c.T408A eller c.T408G
English: After follow up in the OLE, the mean change from baseline in LVMi in patients with left ventricular hypertrophy at baseline at Month 36 was -30.0 (95%) CI: -57.9, -2.2; n=4) and at Month 48
Norwegian Bokmål: Etter oppfølging i den åpne forlengelsesstudien var gjennomsnittlig endring i LVMi fra baseline ved måned 36 -30,0 (95 % KI: -57,9, -2,2; n= 4) og ved måned 48 33,1 (KI -60,9, -5,4; n=4) hos pasienter med venstre ventrikkel hypertrofi ved baseline.
English: c.648T>A or c.648T>G
Norwegian Bokmål: c.648T>A eller c.648T>G c.T648A eller c.T648G
English: c.3G>A or c.3G>T or c.3G>C c.G3A or c.G3T or c.G3C
Norwegian Bokmål: c.3G>A eller c.3G>T eller c.3G>C
English: c.T702G or c.T702A
Norwegian Bokmål: c.702T>G eller c.702T>A c.T702G eller c.T702A
English: c.242G>A or c.243G>A
Norwegian Bokmål: c.242G>A eller c.243G>A c.G242A eller c.G243A
English: c.778G>C or c.778G>A
Norwegian Bokmål: c.778G>C eller c.778G>A c.G778C eller c.G778A